PHAR
Pharming Group N.V.
13.66
1 x 17.34
1 x 12.17
bid
ask
-
0.23
1.69%
1 @ 04:00 PM
13.72 +0.06 (0.47%)
| Ytd | -22.72% | |
| 1y | 27.51% |
13.60
day range
13.80
9.54
52 week range
21.34
| Open | 13.80 | Prev Close | 13.89 | Low | 13.60 | High | 13.80 | Mkt Cap | 964.45M |
| Vol | 4.50K | Avg Vol | 11.12K | EPS | 0.19 | P/E | 71.87 | Forward P/E | 32.70 |
| Beta | 0.12 | Short Ratio | 0.40 | Inst. Own | 0.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-31 | 50-d Avg | 13.79 | 200-d Avg | 15.63 | 1yr Est | 34.60 |
| Income Statement | |||
| Total Revenue | 72.45M | ||
| Revenues (USD) | 83.27M | ||
| Cost of Revenue | 6.64M | ||
| Gross Profit | 65.80M | ||
| Operating Expenses | 70.71M | ||
| Research and Development Expense | 25.56M | ||
| Selling, General and Administrative Expense | 45.53M | ||
| Operating Income | -4.91M | ||
| Income Tax Expense | 459.00K | ||
| Net Income | -5.21M | ||
| Net Income Common Stock | -5.21M | ||
| Net Income Common Stock (USD) | -5.99M | ||
| Consolidated Income | -5.21M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -4.75M | ||
| Earning Before Interest & Taxes (USD) | -5.46M | ||
| Weighted Average Shares | 701.68M | ||
| Balance Sheet | |||
| Cash and Equivalents | 53.10M | ||
| Cash and Equivalents (USD) | 61.04M | ||
| Investments | 126.80M | ||
| Investments Current | 117.80M | ||
| Investments Non-Current | 9.01M | ||
| Trade and Non-Trade Receivables | 60.03M | ||
| Current Assets | 295.51M | ||
| Property, Plant & Equipment Net | 23.10M | ||
| Total Assets | 489.37M | ||
| Debt Current | 8.15M | ||
| Total Debt | 116.21M | ||
| Current Liabilities | 112.35M | ||
| Debt Non-Current | 108.06M | ||
| Total Liabilities | 220.41M | ||
| Accumulated Retained Earnings (Deficit) | -281.45M | ||
| Shareholders Equity | 268.96M | ||
| Shareholders Equity (USD) | 309.15M | ||
| Assets Non-Current | 193.85M | ||
| Total Debt (USD) | 133.57M | ||
| Goodwill and Intangible Assets | 130.99M | ||
| Inventory | 64.58M | ||
| Liabilities Non-Current | 108.06M | ||
| Trade and Non-Trade Payables | 103.53M | ||
| Tax Assets | 30.67M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.12M | ||
| Net Cash Flow from Financing | -9.22M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -92.03M | ||
| Capital Expenditure | -238.00K | ||
| Issuance (Purchase) of Equity Shares | 3.88M | ||
| Issuance (Repayment) of Debt Securities | -13.10M | ||
| Net Cash Flow from Investing | -84.76M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -84.52M | ||
| Net Cash Flow from Operations | 1.95M | ||
| Share Based Compensation | 3.23M | ||